Evotec SE - stock earnings
EVO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -39.0 million USD | 196.3 million USD |
| 2023Q2 | -14.9 million USD | 170.3 million USD |
| 2023Q1 | -27.2 million USD | 240.7 million USD |
| 2022Q4 | -27.2 million USD | 240.7 million USD |
| 2022Q3 | -47.3 million USD | 173.9 million USD |
| 2022Q2 | -27.9 million USD | 172.2 million USD |
| 2022Q1 | -31.5 million USD | 187.1 million USD |
| 2021Q4 | -31.5 million USD | 187.1 million USD |
| 2021Q3 | 134.3 million USD | 159.7 million USD |
| 2021Q2 | 60.0 million USD | 138.2 million USD |
| 2021Q1 | 52.7 million USD | 133.1 million USD |
| 2020Q4 | 403000 USD | 140.5 million USD |
| 2020Q3 | -1.4 million USD | 129.4 million USD |
| 2020Q2 | -9.8 million USD | 111.6 million USD |
| 2020Q1 | 22.2 million USD | 119.4 million USD |
| 2019Q4 | 8.4 million USD | 125.1 million USD |
| 2019Q3 | 19.0 million USD | 114.3 million USD |
| 2019Q2 | -2.4 million USD | 103.2 million USD |
| 2019Q1 | 13.1 million USD | 103.8 million USD |
| 2018Q4 | 31.8 million USD | 105.4 million USD |
| 2018Q3 | 34.5 million USD | 96.3 million USD |
| 2018Q2 | 14.3 million USD | 94.8 million USD |
| 2018Q1 | 3.5 million USD | 79.0 million USD |
| 2017Q4 | 11.0 million USD | 86.8 million USD |
| 2017Q3 | 2.9 million USD | 67.5 million USD |
| 2017Q2 | 3.3 million USD | 53.2 million USD |
| 2017Q1 | 7.1 million USD | 50.2 million USD |
| 2016Q4 | 15.4 million USD | 43.9 million USD |
| 2016Q3 | 8.8 million USD | 45.2 million USD |
| 2016Q2 | 4.1 million USD | 38.0 million USD |
| 2016Q1 | -761000 USD | 37.5 million USD |
| 2015Q4 | 5.8 million USD | 39.5 million USD |
| 2015Q3 | -2.9 million USD | 33.2 million USD |
| 2015Q2 | 14.6 million USD | 33.4 million USD |
| 2015Q1 | -1.1 million USD | 21.5 million USD |
| 2014Q4 | 1.0 million USD | 30.6 million USD |
| 2014Q3 | -3.6 million USD | 18.8 million USD |
| 2014Q2 | -422000 USD | 22.5 million USD |
| 2014Q1 | -4.0 million USD | 17.6 million USD |
| 2013Q4 | -20.6 million USD | 25.6 million USD |
| 2013Q3 | -283000 USD | 23.6 million USD |
| 2013Q2 | -1.7 million USD | 19.6 million USD |
| 2013Q1 | -2.9 million USD | 17.1 million USD |
| 2012Q4 | -5.1 million USD | 23.1 million USD |
| 2012Q3 | 5.9 million USD | 22.2 million USD |
| 2012Q2 | 3.7 million USD | 21.9 million USD |
| 2012Q1 | -2.0 million USD | 20.1 million USD |
| 2011Q4 | -2.5 million USD | 20.4 million USD |
| 2011Q3 | 8.4 million USD | 26.3 million USD |
| 2011Q2 | 1.2 million USD | 18.3 million USD |
| 2011Q1 | -362000 USD | 15.1 million USD |
| 2010Q4 | 2.5 million USD | 16.4 million USD |
| 2010Q3 | 647000 USD | 13.9 million USD |
| 2010Q2 | 1.3 million USD | 15.1 million USD |
| 2010Q1 | -11.4 million USD | 13.5 million USD |
| 2009Q4 | -11.4 million USD | 13.5 million USD |
| 2009Q3 | -3.7 million USD | 10.4 million USD |
| 2009Q2 | -8.6 million USD | 10.5 million USD |
| 2009Q1 | -49.3 million USD | 14.4 million USD |
| 2008Q4 | -49.3 million USD | 14.4 million USD |
| 2008Q3 | -3.1 million USD | 10.7 million USD |
| 2008Q2 | -12.0 million USD | 7.2 million USD |
| 2008Q1 | 8.9 million USD | 9.7 million USD |
| 2007Q4 | 8.9 million USD | 9.7 million USD |
| 2007Q3 | -10.5 million USD | 7.4 million USD |
| 2007Q2 | -6.7 million USD | 7.6 million USD |
| 2006Q4 | -11.6 million USD | 34.1 million USD |
| 2006Q3 | -5.9 million USD | 1.7 million USD |
| 2006Q2 | -4.6 million USD | 2.9 million USD |
| 2006Q1 | -5.9 million USD | 2.0 million USD |
| 2005Q4 | -5.2 million USD | 2.3 million USD |
| 2005Q2 | -8.2 million USD | 541810 USD |
| 2005Q1 | -7.7 million USD | 506058 USD |
| 2004Q4 | -5.9 million USD | 352979 USD |
| 2004Q2 | -8.1 million USD | 537815 USD |
| 2004Q1 | -7.0 million USD | 532448 USD |
| 2003Q4 | -6.8 million USD | -287190 USD |
| 2003Q3 | -6.0 million USD | ? USD |
EVO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -95.0 million USD | 820.8 million USD |
| 2022 | -175.7 million USD | 751.4 million USD |
| 2021 | 215.5 million USD | 618.0 million USD |
| 2020 | 6.3 million USD | 500.9 million USD |
| 2019 | 38.1 million USD | 446.4 million USD |
| 2018 | 84.2 million USD | 375.4 million USD |
| 2017 | 24.3 million USD | 257.6 million USD |
| 2016 | 27.5 million USD | 164.5 million USD |
| 2015 | 16.5 million USD | 127.7 million USD |
| 2014 | -7.0 million USD | 89.5 million USD |
| 2013 | -25.4 million USD | 85.9 million USD |
| 2012 | 2.5 million USD | 87.3 million USD |
| 2011 | 6.7 million USD | 80.1 million USD |
| 2010 | 3.3 million USD | 55.3 million USD |
| 2009 | -45.5 million USD | 42.7 million USD |
| 2008 | -78.3 million USD | 39.6 million USD |
| 2007 | -11.2 million USD | 32.9 million USD |
| 2006 | -32.5 million USD | 67.4 million USD |
| 2005 | -33.6 million USD | 64.1 million USD |
| 2004 | -29.5 million USD | 1.9 million USD |
| 2003 | -33.2 million USD | 3.6 million USD |
| 2002 | -23.9 million USD | ? USD |
| 2001 | -12.8 million USD | ? USD |
EVO
Price: $5.28
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.29 USD
P/E Ratio: -26
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 14985
Market Capitalization: 2.7 billion
Average Dividend Frequency: 12